News

Filter

Current filters:

Bristol-Myers Squibb

1 to 9 of 2876 results

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

23-02-2015

US pharma major Bristol-Myers Squibb has signed a definitive agreement to acquire all of the outstanding…

Bristol-Myers SquibbF001287FlexusLicensingMergers & AcquisitionsOncologyPharmaceuticalRigel Pharmaceuticals

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck

13-02-2015

German pharmaceuticals and chemicals major Merck KGaA is to end the co-promotion of Erbitux (cetuximab)…

Bristol-Myers SquibbErbituxJapanLicensingMerck & CoOncologyPharmaceutical

FDA approves Bristol-Myers Squibb's Evotaz in HIV-1

FDA approves Bristol-Myers Squibb's Evotaz in HIV-1

02-02-2015

US drug major Bristol-Myers Squibb has received approval from the US Food and Drug Administration for…

Anti-viralsBristol-Myers SquibbEvotazPharmaceuticalRegulation

Fourth quarter Bristol-Myers Squibb results disappoint

Fourth quarter Bristol-Myers Squibb results disappoint

27-01-2015

Although the fourth quarter financial results from US drug major Bristol-Myers Squibb beat analyst estimates,…

Bristol-Myers SquibbFinancialPharmaceuticalUnited StatesUSA

Moderate growth forecast for colorectal cancer drug market

22-01-2015

The value of the colorectal cancer (CRC) therapeutics market will increase moderately, from $8.3 billion…

AvastinBayerBristol-Myers SquibbErbituxGlobalMarkets & MarketingMerck KGaAOncologyPharmaceuticalRocheStivarga

Bristol-Myers to promote Caforio to CEO post; other appointments

Bristol-Myers to promote Caforio to CEO post; other appointments

21-01-2015

US pharma major Bristol-Myers Squibb yesterday announced a number of leadership changes approved by its…

BoardroomBristol-Myers SquibbManagementPharmaceuticalUSA

Bristol-Myers stops Opdivo NSCLC study early on good results

12-01-2015

US pharma major Bristol-Myers Squibb says that an open-label, randomized Phase III study evaluating Opdivo…

Bristol-Myers SquibbOncologyOpdivoPharmaceuticalResearch

1 to 9 of 2876 results

COMPANY SPOTLIGHT

Menarini

Back to top